quality of life and disability worldwide. Principal progress in the development of new
anticancerРетроэлементы как мишени таргетной терапии опухолей (обзор) in
targeted antitumor
therapy (review). Research Results in Biomedicine. 2024; 10(1): 5-22. Russian]. DOI: 10
Gareev, Ilgiz,
Beylerli, Ozal,
Tamrazov, Rasim,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2023) effectively
target various structures within the central nervous system (CNS). MiRNA-based
therapy stands out
Дьяконов, В.А.,
Джемилева, Л.У.,
Джемилев, У.М.,
D'yakonov, V.A.,
Dzhemileva, L.U.,
Dzhemilev, U.M. (2017) The search for new, effective, and low-toxic
anticancer agents is one of the most important tasks
Beylerli, Ozal,
Beilerli, Aferin,
Shumadalova, Alina,
Wang, Xiaoxiong,
Yang, Mingchun,
Sun, Hanran,
Teng, Lei (2022) and tumor surgery are limited by
anticancer drug resistance and tumor invasion. Evidence suggests
There have been great advances in the
therapy of cancer and leukemia. However, there are still many